BANK OF MONTREAL /CAN/ - ADAMIS PHARMACEUTICALS CORP ownership

ADAMIS PHARMACEUTICALS CORP's ticker is ADMP and the CUSIP is 00547W208. A total of 49 filers reported holding ADAMIS PHARMACEUTICALS CORP in Q3 2020. The put-call ratio across all filers is 0.27 and the average weighting 0.0%.

Quarter-by-quarter ownership
BANK OF MONTREAL /CAN/ ownership history of ADAMIS PHARMACEUTICALS CORP
ValueSharesWeighting
Q4 2020$16,000
-11.1%
22,8000.0%0.00%
Q3 2020$18,000
-93.4%
22,800
-81.2%
0.00%
Q4 2018$274,000
+42.7%
121,400
+121.5%
0.00%
Q3 2018$192,000
-73.6%
54,800
-75.9%
0.00%
Q2 2018$728,000227,6000.00%
Other shareholders
ADAMIS PHARMACEUTICALS CORP shareholders Q3 2020
NameSharesValueWeighting ↓
BARD ASSOCIATES INC 124,300$87,0000.04%
Hayden Royal, LLC 16,000$12,272,0000.01%
Global Strategic Investment Solutions, LLC 23,000$16,0000.01%
Founders Capital Management 8,000$6,0000.01%
Cable Hill Partners, LLC 20,000$14,0000.00%
Jacobi Capital Management LLC 25,000$18,0000.00%
Stonebridge Capital Advisors LLC 22,000$15,0000.00%
B. Riley Wealth Advisors, Inc. 37,520$27,0000.00%
Firestone Capital Management 5,200$4,0000.00%
MGO ONE SEVEN LLC 10,615$7,0000.00%
View complete list of ADAMIS PHARMACEUTICALS CORP shareholders